Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5(+) hematological malignancies. (linkinghub.elsevier.com)

Authors: Cheng J … Zhu X Journal: Cell Reports Medicine Published: 2026-02-17 DOI: https://doi.org/10.1016/j.xcrm.2026.102584